ARCHIVES

PET Tracer Drug Approved, Developed At Weill Cornell

This article is from The Cancer Letter archive.

Vol. 27 No. 9 | September 24, 2004

Download PDF Visit The Full Archive

Related Articles

Two-Year Remission While Taking Gleevec Puts Patients Into Normal Mortality Rate

March 25, 2011

Task Force Recommendations Submitted For Control/Centers New Division

August 3, 1979

New Grant Programs In Radiology, Clinical Correlates, Ok’d

June 21, 1991

In Brief: DeVita, Fri To Share Hammer Cancer Prize; Dessureau To Retire Early; NCI Appointments

December 8, 1989

Black, Hispanic Cancer Initiatives to Be Funded, Formed

June 7, 1991

NCI Is Considering New Core Grants For Prostate, Breast Research Centers

April 19, 1991